In this study, we demonstrated that intestinal HIF2α is critical for activating a transcriptional program that may increase iron availability through the upregulation of iron metabolism genes expression, and promote EE, providing a potential strategy for the treatment of EE diseases. The gene discussed is EPAS1; the disease is ethylmalonic encephalopathy.